Less Ads, More Data, More Tools Register for FREE

Pin to quick picksValiRx Share News (VAL)

Share Price Information for ValiRx (VAL)

Share Price is delayed by 15 minutes
Get Live Data
0.185    0.00 (0.00%)
Bid:
0.18
Ask:
0.19
Spread: 0.01 (5.556%)
Market Cap: £1.37m
VAL Live PriceLast checked at - London Stock Exchange

Intraday ValiRx Share Chart

ValiRx News

Contract wins round-up: LO-Q, Motive TV, Plexus ...
11 Oct 2012

Contract wins round-up: LO-Q, Motive TV, Plexus ...

Lo-Q has announced its second contract win of the week, as an unnamed major US theme park operator has signed up to use the firm's virtual queueing sy...

Small cap round-up: ValiRx, Transense, Sweett
29 May 2012

Small cap round-up: ValiRx, Transense, Sweett

Shares in ValiRx, the life sciences firm, leapt almost 40% on Tuesday after it said independent trials had confirmed the effectiveness of its prostate...

Small caps round-up: Cello, DDD, Kewill...
15 May 2012

Small caps round-up: Cello, DDD, Kewill...

Marketing firm Cello Group has reported good trading during the first three months of the year, reflecting 'the strong pipeline of work secured at the...

Small caps round-up: James Cropper, ValiRx, ReNeuron
27 Apr 2012

Small caps round-up: James Cropper, ValiRx, ReNeuron

James Cropper, a specialist paper and materials group, has said that pre-execptional profit before tax is set to be in line with market expectations. ...

Small caps round-up: Rock Solid, ValiRx, InternetQ, Quindell
2 Apr 2012

Small caps round-up: Rock Solid, ValiRx, InternetQ, Quindell

Rock Solid Images, an oil equipment, services and distribution firm, has received an offer from Thalassa Holdings to acquire up to 25.89 per cent of t...

Small caps round-up: Caza, Tower Resources, Noventa...
2 Feb 2012

Small caps round-up: Caza, Tower Resources, Noventa...

Mining firm Noventa says that operations have suffered from a "plague" of beetles as a result of tropical storms which have hit the firm's Marropino s...

Valirx wins Canadian patent for 'gene-silencing' technology
15 Dec 2011

Valirx wins Canadian patent for 'gene-silencing' technology

ValiRx, the AIM listed life sciences firm, saw its share price surge on news that its 'gene-silencing' technology has received patent approval in Cana...

ValiRx Begins Clinical Validation Of HPV Test
15 Jul 2010

ValiRx Begins Clinical Validation Of HPV Test

LONDON (Dow Jones)--ValiRx PLC (VAL.LN), a life science company with a focus on cancer diagnostics and therapeutics for personalized medicine, said Th...